Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Revenue

In the year 2025, Duality Biotherapeutics had annual revenue of 1.85B CNY, down -4.61%. Duality Biotherapeutics had revenue of 622.80M in the half year ending December 31, 2025.

• Revenue: 1.85B CNY
• Revenue Growth: -4.61%
• P/S Ratio: 7.86
• Revenue / Employee: 8.02M CNY
• Employees: 231
• Market Cap: 16.20B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.85B	-89.52M	-4.61%
Dec 31, 2024	1.94B	154.72M	8.66%
Dec 31, 2023	1.79B	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 14, 2026

Data Sources Report a data error